A Study to Evaluate the Efficacy and Safety of KH001 in Patients with Dentin Hypersensitivity

NCT06264453 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

171

Enrollment

INDUSTRY

Sponsor class

Conditions

Dentin Hypersensitivity

Interventions

DRUG: KH001
DRUG: Placebo

Sponsor

HysensBio Co., Ltd